Stock exchange RSS

Latest Stock exchange News & Press Releases

  • Altimmune Rumored to Be Acquired by Novo Holdings for $7-$10 Billion
  • Altimmune, Inc., a clinical-stage biotechnology company known for its cutting-edge intranasal vaccines and immunotherapy platforms, is reportedly in advanced talks for a potential acquisition by Novo Holdings, the investment arm of Danish pharmaceutical giant Novo Nordisk. Sources familiar with the matter have suggested that the deal could be valued between $7 billion and $10 billion.
  • By Bio Rumors - December 19, 2024
badge
americangreencbdlogo
badge
motivewavelogo100x82_for_light_backgrounds_darkgray
badge
motivewavelogo100x82_for_light_backgrounds_darkgray
badge
motivewavelogo100x82_for_light_backgrounds_darkgray
badge
motivewavelogo100x82_for_light_backgrounds_darkgray
badge
bt_screensaver_2_
badge
motivewavelogo153x125_for_light_backgrounds_darkgray
badge
bt_screensaver_2_